Cargando…

Atomoxetine might be more effective in improving sluggish cognitive tempo symptoms after switching from methylphenidate: A case report

Although there is no proven evidence regarding pharmacotherapy of Sluggish Cognitive Tempo (SCT), we experienced atomoxetine had more effects in decreasing SCT symptoms after switching from methylphenidate in a case with SCT and subthreshold ADHD.

Detalles Bibliográficos
Autores principales:	Tahıllıoğlu, Akın, Ercan, Eyüp Sabri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869347/ https://www.ncbi.nlm.nih.gov/pubmed/33598212 http://dx.doi.org/10.1002/ccr3.3592

Ejemplares similares

DRD4 genotyping may differentiate symptoms of attention-deficit/hyperactivity disorder and sluggish cognitive tempo
por: Bolat, Hilmi, et al.
Publicado: (2020)

Sluggish Cognitive Tempo in Pediatric Sickle Cell Disease
por: Hardy, Steven J., et al.
Publicado: (2022)

Transition from Methylphenidate to Atomoxetine: reasons for switching and clinical outcome
por: Cassar, Fabrizia, et al.
Publicado: (2021)

Examining the Role of Attention Deficits in the Social Problems and Withdrawn Behavior of Children With Sluggish Cognitive Tempo Symptoms
por: Yung, Trevor W. K., et al.
Publicado: (2021)

Social Functioning in Youth with Attention-Deficit/Hyperactivity Disorder and Sluggish Cognitive Tempo
por: Ferretti, Nicole M., et al.
Publicado: (2019)

Normal executive attention but abnormal orienting attention in individuals with sluggish cognitive tempo
por: Kim, Kiho, et al.
Publicado: (2021)

Field of daydreams? Integrating mind wandering in the study of sluggish cognitive tempo and ADHD
por: Becker, Stephen P., et al.
Publicado: (2021)

Methylphenidate-induced Exacerbation of Chorea in a Child Resolved with Switching to Atomoxetine
por: Ekinci, Ozalp, et al.
Publicado: (2020)

Sluggish cognitive tempo is associated with autistic traits and anxiety disorder symptoms in children with attention-deficit/hyperactivity disorder
por: Ekinci, Ozalp, et al.
Publicado: (2020)

The Effect of Eye-Feedback Training on Orienting Attention in Young Adults With Sluggish Cognitive Tempo
por: Kim, Kiho, et al.
Publicado: (2020)

Sleep Disturbance and Its Association With Sluggish Cognitive Tempo and Attention in Pediatric Brain Tumor Survivors
por: Olsthoorn, Ineke M., et al.
Publicado: (2022)

Atomoxetine/Methylphenidate Effects on Social Play Behavior
por: Millichap, J. Gordon
Publicado: (2015)

The Associations Between Sluggish Cognitive Tempo, Internalizing Symptoms, and Academic Performance in Children With Reading Disorder: A Longitudinal Cohort Study
por: Hossain, Bushra, et al.
Publicado: (2022)

Sluggish cognitive tempo and its neurocognitive, social and emotive correlates: a systematic review of the current literature
por: Mueller, Anna Katharina, et al.
Publicado: (2014)

Abnormal physiological responses toward sensory stimulus are related to the attention deficits in children with sluggish cognitive tempo
por: Yung, Trevor W. K., et al.
Publicado: (2022)

Sleep patterns, sluggish cognitive tempo, and daytime sleepiness – a commentary on Fredrick et al. (2022)
por: Sadeghi‐Bahmani, Dena, et al.
Publicado: (2022)

The Deficit of Early Selective Attention in Adults With Sluggish Cognitive Tempo: In Comparison With Those With Attention-Deficit/Hyperactivity Disorder
por: Park, Yelin, et al.
Publicado: (2021)

Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
por: Suzuki, Shiho, et al.
Publicado: (2020)

Treatment Outcomes in an Adult Attention Deficit Hyperactivity Disorder Clinic With a Focus on Executive Functioning and Sluggish Cognitive Tempo
por: Gaur, Sonia, et al.
Publicado: (2020)

Adverse pregnancy outcomes after exposure to methylphenidate or atomoxetine during pregnancy
por: Bro, Søren Pauli, et al.
Publicado: (2015)

Sluggish Cognitive Tempo among Iranian Children and Adolescents: A Validation Study of the Farsi Child and Adolescent Behavior Inventory (CABI)–Parent Version
por: Sadeghi-Bahmani, Dena, et al.
Publicado: (2022)

Mr Sluggish Schizophrenia
por: van Voren, Robert
Publicado: (2021)

Comparative efficacy of methylphenidate and atomoxetine in oppositional defiant disorder comorbid with attention deficit hyperactivity disorder
por: Garg, Jasmin, et al.
Publicado: (2015)

Methylphenidate and atomoxetine prescribing trends in children in the Western Cape Province of South Africa, 2005–2013
por: Joubert, Liezl, et al.
Publicado: (2018)

Systematic Review of Suicidal Behaviors Related to Methylphenidate and Atomoxetine in Patients With Attention Deficit Hyperactivity Disorder
por: Kim, Jae Heon, et al.
Publicado: (2023)

Pattern Classification of Working Memory Networks Reveals Differential Effects of Methylphenidate, Atomoxetine, and Placebo in Healthy Volunteers
por: Marquand, Andre F, et al.
Publicado: (2011)

Shared and Drug-Specific Effects of Atomoxetine and Methylphenidate on Inhibitory Brain Dysfunction in Medication-Naive ADHD Boys
por: Cubillo, Ana, et al.
Publicado: (2014)

Advanced Test of Attention in Children with Attention-Deficit/Hyperactivity Disorder in Japan for Evaluation of Methylphenidate and Atomoxetine Effects
por: Fujioka, Toru, et al.
Publicado: (2016)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
por: Joseph, Alain, et al.
Publicado: (2016)

Single-dose effects of methylphenidate and atomoxetine on functional connectivity during an n-back task in boys with ADHD
por: Kowalczyk, Olivia S., et al.
Publicado: (2023)

A Sluggish Atrioventricular Node
por: Dasari, Tarun W, et al.
Publicado: (2010)

Speedy versus sluggish cells
por: Williams, Ruth
Publicado: (2009)

A pilot study for augmenting atomoxetine with methylphenidate: safety of concomitant therapy in children with attention-deficit/hyperactivity disorder
por: Carlson, Gabrielle A, et al.
Publicado: (2007)

A modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder in Spain
por: Hong, Jihyung, et al.
Publicado: (2009)

Differential therapeutic effects of atomoxetine and methylphenidate in childhood attention deficit/hyperactivity disorder as measured by near-infrared spectroscopy
por: Nakanishi, Yoko, et al.
Publicado: (2017)

Characterization of Amphetamine, Methylphenidate, Nicotine, and Atomoxetine on Measures of Attention, Impulsive Action, and Motivation in the Rat: Implications for Translational Research
por: Higgins, Guy A., et al.
Publicado: (2020)

Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis
por: Hanwella, Raveen, et al.
Publicado: (2011)

Clogged information flow and stock-market sluggishness
por: Vora, Premal P.
Publicado: (2020)

Blunt olfaction in sexually sluggish male rats
por: Shimomi, Yui, et al.
Publicado: (2020)

Comparative efficacy of methylphenidate and atomoxetine in the treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review and meta-analysis
por: Rezaei, Golandam, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_td3od87167pml102tgp3jvmb8q